INTRODUCTION: Panic disorder (PD) is a common anxiety disorder impairing strongly quality of life with high social costs. Effective anti-panic medications exist but a substantial proportion of patients do not fully respond, the available drugs have several side effects and most medications have a delayed onset of their therapeutic effect. Thus, further advances are needed. AREAS COVERED: We review available data on emerging drugs for the treatment of PD including those in development, such as metabotropic glutamate II receptor agonists,

Emerging drugs for panic disorder

Perna G;Caldirola D
2011-01-01

Abstract

INTRODUCTION: Panic disorder (PD) is a common anxiety disorder impairing strongly quality of life with high social costs. Effective anti-panic medications exist but a substantial proportion of patients do not fully respond, the available drugs have several side effects and most medications have a delayed onset of their therapeutic effect. Thus, further advances are needed. AREAS COVERED: We review available data on emerging drugs for the treatment of PD including those in development, such as metabotropic glutamate II receptor agonists,
File in questo prodotto:
File Dimensione Formato  
84 emerging drugs 2012.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Copyright dell'editore
Dimensione 287.77 kB
Formato Adobe PDF
287.77 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11699/32512
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 21
social impact